Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Avalo Therapeutics Inc. buy Wedbush

Avalo Therapeutics Inc.
Start price
€0.041
22.02.25 / 50%
Target price
-
22.02.26
Performance (%)
-
End price
-
23.02.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Avalo Therapeutics Inc. - - -
iShares Core DAX® 4.852% -2.747% 13.097%
iShares Nasdaq 100 3.999% -3.330% 31.335%
iShares Nikkei 225® 4.221% -2.912% 44.472%
iShares S&P 500 3.324% -2.954% 24.360%

Comments by Wedbush for this prediction

In the thread Avalo Therapeutics Inc. diskutieren

Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Wedbush to a "strong-buy" rating.
Ratings data for AVTX provided by MarketBeat

Wedbush 
0
Report Share
22.02.25 Buy -
In the thread Trading Avalo Therapeutics Inc.
Prediction Buy
Perf. (%) -
Target price
Change
Ends at 22.02.26

Die von Wedbush gewählte maximale Laufzeit wurde überschritten

Wedbush 
0
Report Share
23.02.26

Stopped prediction by Wedbush for Avalo Therapeutics Inc.

buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.041
20.03.25
€16.51
20.03.26
-
21.03.26

Wedbush 
20.03.25 50%
buy
Avalo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.041
21.02.25
€17.18
21.02.26
-
22.02.26

Wedbush 
21.02.25 50%